The nausea and other gastrointestinal side effects of weight loss drugs like Novo Nordisk’s Wegovy or Eli Lilly’s Zepbound will limit how much these drugs can help patients and stunt the overall ...

A Trump administration deal to cut prices for popular weight-loss drugs like Wegovy and Zepbound will allow millions more ...

A Trump administration deal to cut prices for popular weight-loss drugs like Wegovy and Zepbound will allow millions more ...

Both medications have similar side effects, such as stomach issues like diarrhea, nausea, and bloating. However, metformin’s ...

The president’s agreement with drug companies involves a range of prices, depending on dose, product and how you’re paying.

This article was reviewed by Darragh O’Carroll, MD. GLP-1 for Weight Loss: Everything You Need to Know Key takeaways: GLP-1s ...

Denmark-based Novo Nordisk, which makes Ozempic, Rybelsus and Wegovy; and Indianapolis-based Eli Lilly, which makes Zepbound, ...

A new ‘microdosing’ trend lets pharmacies offer compounded versions of GLP-1 drugs even after the Food and Drug ...

By subsidizing Wegovy and Zepbound, Trump may deliver one of the most consequential public-health interventions in decades.

A small study helps explain why some people taking Wegovy and similar weight-loss drugs cut back on alcohol, offering insight into potential new addiction therapies ...

U.S. sales of Lilly’s weight-loss treatment Zepbound nearly tripled, to $3.57 billion, in the third quarter. Meanwhile, ...

The drugmaker said it would launch late-stage trials of the drug after participants lost as much as 20% of their body weight.